Cyclo Therapeutics Stock Technical Analysis

CYTHW Stock  USD 0.24  0.01  4.35%   
As of the 2nd of March, Cyclo Therapeutics shows the risk adjusted performance of 0.0934, and Mean Deviation of 6.01. Cyclo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cyclo Therapeutics market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Cyclo Therapeutics is priced correctly, providing market reflects its regular price of 0.24 per share. As Cyclo Therapeutics appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Cyclo Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cyclo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cyclo
  
Cyclo Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Cyclo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cyclo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cyclo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cyclo Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cyclo Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Cyclo Therapeutics Trend Analysis

Use this graph to draw trend lines for Cyclo Therapeutics. You can use it to identify possible trend reversals for Cyclo Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cyclo Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cyclo Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cyclo Therapeutics applied against its price change over selected period. The best fit line has a slop of    , which means Cyclo Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.31, which is the sum of squared deviations for the predicted Cyclo Therapeutics price change compared to its average price change.

About Cyclo Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cyclo Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cyclo Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cyclo Therapeutics price pattern first instead of the macroeconomic environment surrounding Cyclo Therapeutics. By analyzing Cyclo Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cyclo Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cyclo Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 2025 (projected)
Days Sales Outstanding14.5941.537.3531.08
PTB Ratio16.315.464.917.66

Cyclo Therapeutics March 2, 2025 Technical Indicators

Most technical analysis of Cyclo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cyclo from various momentum indicators to cycle indicators. When you analyze Cyclo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Cyclo Stock Analysis

When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.